

IN BRIEF: Evgen Pharma files brain tumour treatment request with FDA


IN BRIEF: Evgen Pharma encouraged by early data for SFX-01


AIM WINNERS & LOSERS: Star Phoenix wins new deal; Ebiquity revenue up


Evgen Pharma halts trial as SFX-01 drug fails to help Covid patients


AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle


(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the results of the interim safety and futility assessment readout of...


UK shareholder meetings calendar - next 7 days


TRADING UPDATES: GB Group rebuilds dividend; IPF ups 2021 profit view